CD24 expression is a poor prognostic marker in endometrial carcinoma


Karahan N., Guney M., Oral B., Kapucuoglu N., Mungan T.

EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, vol.27, no.5, pp.500-504, 2006 (Peer-Reviewed Journal) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 27 Issue: 5
  • Publication Date: 2006
  • Journal Name: EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY
  • Journal Indexes: Science Citation Index Expanded, Scopus
  • Page Numbers: pp.500-504

Abstract

Objective: CD24 is a cell adhesion molecule that has been implicated in metastatic tumor progression of various solid tumors. Its expression is known to be related to the prognosis of several kinds of tumors. This study was designed to examine the prognostic significance of CD24 in endometrial cancer patients.